Psychometric validation of the Brain Symptom and Impact Questionnaire (BASIQ) version 1.0 to assess quality of life in patients with brain metastases

Nemica Thavarajah, Saurabh Ray, Gillian Bedard, Liying Zhang, David Cella, Erin Wong, Cyril Danjoux, May Tsao, Elizabeth Barnes, Arjun Sahgal, Hany Soliman, Natalie Pulenzas, Breanne Lechner, Edward Chow

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

OBJECTIVE: To test the reliability, clinical and psychometric validity of the Brain Symptom and Impact Questionnaire (BASIQ) in patients with brain metastases.

METHODS: Brain metastases patients were interviewed using the BASIQ, Functional Assessment of Cancer-Brain (FACT-Br) and FACT-General (FACT-G) at baseline, with a follow-up assessment at 1 month.

RESULTS: Forty patients had complete one data and the median age was 64 years. Patients with higher KPS, ECOG of 2, primary breast cancer, or >3 brain metastases, scored higher on the symptom scale of the BASIQ. All subscales showed no significant change in patient symptoms from baseline to follow-up.

CONCLUSION: This study supports that the reliability, clinical and psychometric validity of BASIQ to be used in brain metastases patients.

Original languageEnglish (US)
Pages (from-to)11-23
Number of pages13
JournalCNS oncology
Volume4
Issue number1
DOIs
StatePublished - Jan 1 2015

Keywords

  • BASIQ
  • brain metastases
  • field-testing
  • psychometric validation
  • quality of life
  • questionnaire

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Psychometric validation of the Brain Symptom and Impact Questionnaire (BASIQ) version 1.0 to assess quality of life in patients with brain metastases'. Together they form a unique fingerprint.

  • Cite this

    Thavarajah, N., Ray, S., Bedard, G., Zhang, L., Cella, D., Wong, E., Danjoux, C., Tsao, M., Barnes, E., Sahgal, A., Soliman, H., Pulenzas, N., Lechner, B., & Chow, E. (2015). Psychometric validation of the Brain Symptom and Impact Questionnaire (BASIQ) version 1.0 to assess quality of life in patients with brain metastases. CNS oncology, 4(1), 11-23. https://doi.org/10.2217/cns.14.49